Giusti was also named to the list in 2009 for breaking down industry barriers.
“Kathy Giusti has been inspiring patients and the research community since she first took that powerful and visionary step. Her and MMRF’s success has been built on three cornerstones: setting the vision and plan; hiring the talented people; and building a strong collaborative community,” the PharmaVOICE 100 issue said.
Meryl Zausner, a member of the MMRF Board of Directors and executive vice president and chief financial officer of Novartis Corp., was also recognized as a 2014 PharmaVOICE 100 honoree for her work in empowering women in the industry.
"This is a well-deserved honor for both Kathy and Meryl,” said Walter M. Capone, president and chief executive officer of the MMRF.
"Their leadership, commitment and advocacy has enabled the tremendous successes of the MMRF and will ensure our continued focus on speed, innovation and results for patients."
Multiple Myeloma Research Foundation was established in 1998 by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's own diagnosis with multiple myeloma.
Click here to follow Daily Voice New Canaan and receive free news updates.